<DOC>
	<DOCNO>NCT02041650</DOCNO>
	<brief_summary>This protocol describe pilot study intend test hypothesis patient acute coronary syndrome ( ACS ) cause plaque erosion stabilize effective antithrombotic treatment without stent implantation , thereby avoid early late complication relate percutaneous coronary intervention ( PCI ) .</brief_summary>
	<brief_title>Paradigm Shift Treatment Patients With ACS</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Men nonpregnant woman &gt; 18 year age &lt; 75 year age Patients undergo cardiac catheterization ACS . Patients STEMI , NSTEMI , UAP include . STEMI define continuous chest pain &gt; 30 minute , arrival hospital within 12 hour chest pain onset , STsegment elevation &gt; 0.1 mV least two contiguous lead , new leave bundlebranch block 12lead electrocardiogram ( ECG ) , elevate cardiac marker ( troponin T/I creatine kinaseMB ) . NSTEMI define progressive crescendo pattern angina angina rest , absence STsegment elevation 12lead ECG , elevate cardiac marker . UAP define new onset angina , progressive crescendo pattern angina , angina rest . Culprit lesion locate native coronary artery TIMI flow grade 3 diameter stenosis &lt; 70 % angiogram Definite erosion define OCT Patients able provide write informed consent Left ventricular ejection fraction &lt; 30 % . Life expectancy &lt; 1 year . Contraindication contrast medium . Creatinine level &gt; 2.0 mg/dL endstage kidney disease . Serious liver dysfunction . Patients hemodynamic electrical instability ( include shock ) . Any contraindication use ticagrelor . Investigator consider patient suitable .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>